FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:229-234 July 23, 1998 Number 4 Next

Abstract Full Text PDF Letters Add to Personal Archive Add to Citation Manager E-mail When Cited PubMed Citation

From the Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio (S.M.H.); the Department of Medicine, University of Kuopio, Kuopio, Finland (S.L., K.P., M.L.); and the Department of Medicine, Turku University, Turku, Finland (T.R.).

Address reprint requests to Dr. Haffner at the Department of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78284-7873.

Full Text of this Article

Related Letters:

Diabetes and Coronary Heart Disease
Simons L. A., Simons J., Engler R. L., McGurk C., Harper R., McCance D. R., Krankenberg H., Lauer B., Schuler G., Haffner S. M., Lehto S., Laakso M.
Extract | Full Text  
N Engl J Med 1998; 339:1714-1716, Dec 3, 1998. Correspondence

This article has been cited by other articles:

• Nauck, M. A., Ratner, R. E., Kapitza, C., Berria, R., Boldrin, M., Balena, R. (2009). Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic Control and Lowers Body Weight in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone: A double-blind placebo-controlled study. Diabetes Care 32: 1237-1243 [Abstract] [Full Text]  
• Matsushima, S., Kinugawa, S., Yokota, T., Inoue, N., Ohta, Y., Hamaguchi, S., Tsutsui, H. (2009). Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 297: H409-H416 [Abstract] [Full Text]  
• Verges, B., Florentin, E., Baillot-Rudoni, S., Petit, J.-M., Brindisi, M. C., Pais de Barros, J.-P., Lagrost, L., Gambert, P., Duvillard, L. (2009). Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes. J. Lipid Res. 50: 1209-1215 [Abstract] [Full Text]  
• Hofsten, D. E., Logstrup, B. B., Moller, J. E., Pellikka, P. A., Egstrup, K. (2009). Abnormal glucose metabolism in acute myocardial infarction influence on left ventricular function and prognosis.. J Am Coll Cardiol Img 2: 592-599 [Abstract] [Full Text]  
• Verhaert, D., Thomas, J. D. (2009). Dysglycemia and acute myocardial infarction the role of echocardiography.. J Am Coll Cardiol Img 2: 600-603 [Full Text]  
• Parving, H.-H., Brenner, B. M., McMurray, John. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Ghadanfar, M., Weissbach, N., Xiang, Z., Armbrecht, J., Pfeffer, M. A. (2009). Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant 24: 1663-1671 [Abstract] [Full Text]  
• Huhn, R., Heinen, A., Weber, N. C., Kerindongo, R. P., Oei, G. T. M. L., Hollmann, M. W., Schlack, W., Preckel, B. (2009). Helium-Induced Early Preconditioning and Postconditioning Are Abolished in Obese Zucker Rats in Vivo. J. Pharmacol. Exp. Ther. 329: 600-607 [Abstract] [Full Text]  
• Boardman, N., Hafstad, A. D., Larsen, T. S., Severson, D. L., Aasum, E. (2009). Increased O2 cost of basal metabolism and excitation-contraction coupling in hearts from type 2 diabetic mice. Am. J. Physiol. Heart Circ. Physiol. 296: H1373-H1379 [Abstract] [Full Text]  
• Young, L. H., Wackers, F. J. Th., Chyun, D. A., Davey, J. A., Barrett, E. J., Taillefer, R., Heller, G. V., Iskandrian, A. E., Wittlin, S. D., Filipchuk, N., Ratner, R. E., Inzucchi, S. E., for the DIAD Investigators, (2009). Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes: The DIAD Study: A Randomized Controlled Trial. JAMA 301: 1547-1555 [Abstract] [Full Text]  
• O'Connor, P. J., Sperl-Hillen, J. M. (2009). The Role of Diabetes Educators in the Medical Home. Diabetes Spectr. 22: 124-126 [Full Text]  
• Younis, N., Soran, H., Hassanein, M. (2009). Cardiovascular disease and intensive glucose lowering in type 2 diabetes. QJM 102: 293-296 [Full Text]  
• Bergman, A. J., Cote, J., Maes, A., Zhao, J. J., Roadcap, B. A., Sun, L., Valesky, R. J., Yang, A., Keymeulen, B., Mathijs, Z., De Smet, M., Laethem, T., Davies, M. J., Wagner, J. A., Herman, G. A. (2009). Effect of Sitagliptin on the Pharmacokinetics of Simvastatin. J Clin Pharmacol 49: 483-488 [Full Text]  
• Rahman, S., Aziz Al-Safi Ismail, , Shaiful Bahari Ismail, , Nyi Nyi Naing, , Abdul Rashid Abdul Rahman, (2009). Increased arterial stiffness in normoglycaemic offspring of newly diagnosed, never treated type 2 diabetic and impaired glucose tolerance parents. British Journal of Diabetes & Vascular Disease 9: 65-68 [Abstract]  
• Raz, I., Wilson, P. W.F., Strojek, K., Kowalska, I., Bozikov, V., Gitt, A. K., Jermendy, G., Campaigne, B. N., Kerr, L., Milicevic, Z., Jacober, S. J. (2009). Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial. Diabetes Care 32: 381-386 [Abstract] [Full Text]  
• Worm, S. W., De Wit, S., Weber, R., Sabin, C. A., Reiss, P., El-Sadr, W., Monforte, A. D., Kirk, O., Fontas, E., Dabis, F., Law, M. G., Lundgren, J. D., Friis-Moller, N. (2009). Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). Circulation 119: 805-811 [Abstract] [Full Text]  
• Dagenais, G. R. MD, St-Pierre, A. PhD, Gilbert, P. MD, Lamarche, B. PhD, Despres, J.-P. PhD, Bernard, P.-M. MSc, Bogaty, P. MD (2009). Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease. CMAJ 180: 40-47 [Abstract] [Full Text]  
• Bowes, A. J., Khan, M. I., Shi, Y., Robertson, L., Werstuck, G. H. (2009). Valproate Attenuates Accelerated Atherosclerosis in Hyperglycemic ApoE-Deficient Mice: Evidence in Support of a Role for Endoplasmic Reticulum Stress and Glycogen Synthase Kinase-3 in Lesion Development and Hepatic Steatosis. Am. J. Pathol. 174: 330-342 [Abstract] [Full Text]  
• Hiukka, A., Westerbacka, J., Leinonen, E. S., Watanabe, H., Wiklund, O., Hulten, L. M., Salonen, J. T., Tuomainen, T.-P., Yki-Jarvinen, H., Keech, A. C., Taskinen, M.-R. (2008). Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus. J Am Coll Cardiol 52: 2190-2197 [Abstract] [Full Text]  
• Warner, J. J., Weideman, R. A., Kelly, K. C., Brilakis, E. S., Banerjee, S., Cunningham, F., Harford, W. V., Kazi, S., Little, B. B., Cryer, B. (2008). The Risk of Acute Myocardial Infarction with Etodolac Is not Increased Compared to Naproxen: A Historical Cohort Analysis of a Generic COX-2 Selective Inhibitor. J CARDIOVASC PHARMACOL THER 13: 252-260 [Abstract]  
• Authors/Task Force Members, , Van de Werf, F., Bax, J., Betriu, A., Blomstrom-Lundqvist, C., Crea, F., Falk, V., Filippatos, G., Fox, K., Huber, K., Kastrati, A., Rosengren, A., Steg, P. G., Tubaro, M., Verheugt, F., Weidinger, F., Weis, M., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Silber, S., Aguirre, F. V., Al-Attar, N., Alegria, E., Andreotti, F., Benzer, W., Breithardt, O., Danchin, N., Mario, C. D., Dudek, D., Gulba, D., Halvorsen, S., Kaufmann, P., Kornowski, R., Lip, G. Y. H., Rutten, F. (2008). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:. Eur Heart J 29: 2909-2945 [Full Text]  
• Norhammar, A, Stenestrand, U, Lindback, J, Wallentin, L, on behalf of the Register of Information and Knowl, (2008). Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Heart 94: 1565-1570 [Abstract] [Full Text]  
• Duncan, E. R., Crossey, P. A., Walker, S., Anilkumar, N., Poston, L., Douglas, G., Ezzat, V. A., Wheatcroft, S. B., Shah, A. M., Kearney, M. I. (2008). Effect of Endothelium-Specific Insulin Resistance on Endothelial Function In Vivo. Diabetes 57: 3307-3314 [Abstract] [Full Text]  
• Krasuski, R. A. (2008). Primary Prevention and Statins: Is It Just About Going to Class?. Mayo Clin Proc. 83: 1313-1315 [Full Text]  
• Ahanchi, S. S., Varu, V. N., Tsihlis, N. D., Martinez, J., Pearce, C. G., Kapadia, M. R., Jiang, Q., Saavedra, J. E., Keefer, L. K., Hrabie, J. A., Kibbe, M. R. (2008). Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome. Am. J. Physiol. Heart Circ. Physiol. 295: H2388-H2398 [Abstract] [Full Text]  
• McLean, D. L., McAlister, F. A., Johnson, J. A., King, K. M., Makowsky, M. J., Jones, C. A., Tsuyuki, R. T., for the SCRIP-HTN Investigators, (2008). A Randomized Trial of the Effect of Community Pharmacist and Nurse Care on Improving Blood Pressure Management in Patients With Diabetes Mellitus: Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). Arch Intern Med 168: 2355-2361 [Abstract] [Full Text]  
• Ogawa, H., Nakayama, M., Morimoto, T., Uemura, S., Kanauchi, M., Doi, N., Jinnouchi, H., Sugiyama, S., Saito, Y., for the Japanese Primary Prevention of Atheroscler, (2008). Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial. JAMA 300: 2134-2141 [Abstract] [Full Text]  
• Nauck, M. A (2008). Liraglutide, a once-daily human GLP-1 analogue. British Journal of Diabetes & Vascular Disease 8: S26-S33 [Abstract]  
• Rosenstock, J., Hollander, P., Chevalier, S., Iranmanesh, A., for the SERENADE Study Group, (2008). SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients: Effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes. Diabetes Care 31: 2169-2176 [Abstract] [Full Text]  
• Giorda, C. B., Avogaro, A., Maggini, M., Lombardo, F., Mannucci, E., Turco, S., Alegiani, S. S., Raschetti, R., Velussi, M., Ferrannini, E., for the Diabetes and Informatics Study Group, (2008). Recurrence of Cardiovascular Events in Patients With Type 2 Diabetes: Epidemiology and risk factors. Diabetes Care 31: 2154-2159 [Abstract] [Full Text]  
• Tribouilloy, C, Rusinaru, D, Mahjoub, H, Tartiere, J-M, Kesri-Tartiere, L, Godard, S, Peltier, M (2008). Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective five-year study. Heart 94: 1450-1455 [Abstract] [Full Text]  
• Dasu, M. R., Devaraj, S., Zhao, L., Hwang, D. H., Jialal, I. (2008). High Glucose Induces Toll-Like Receptor Expression in Human Monocytes: Mechanism of Activation. Diabetes 57: 3090-3098 [Abstract] [Full Text]  
• Cade, W T. (2008). Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting. ptjournal 88: 1322-1335 [Abstract] [Full Text]  
• Mzhavia, N., Yu, S., Ikeda, S., Chu, T. T., Goldberg, I., Dansky, H. M. (2008). Neuronatin: A New Inflammation Gene Expressed on the Aortic Endothelium of Diabetic Mice. Diabetes 57: 2774-2783 [Abstract] [Full Text]  
• Khanderia, U., Pop-Busui, R., Eagle, K. A (2008). Thiazolidinediones in Type 2 Diabetes: A Cardiology Perspective. The Annals of Pharmacotherapy 42: 1466-1474 [Abstract] [Full Text]  
• Kilpatrick, E S (2008). Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J. Clin. Pathol. 61: 977-982 [Abstract] [Full Text]  
• Hartman, I. (2008). Insulin Analogs: Impact on Treatment Success, Satisfaction, Quality of Life, and Adherence. Clin Med Res 6: 54-67 [Abstract] [Full Text]  
• Zaman Huri, H., Lee Qiu Yi, , Pendek, R., Che Zuraini Sulaiman, (2008). Use of Antiplatelet Agents for Primary and Secondary Prevention of Cardiovascular Disease Amongst Type 2 Diabetic Patients. Journal of Pharmacy Practice 21: 287-301 [Abstract]  
• Nicholls, S. J., Tuzcu, E. M., Kalidindi, S., Wolski, K., Moon, K.-W., Sipahi, I., Schoenhagen, P., Nissen, S. E. (2008). Effect of Diabetes on Progression of Coronary Atherosclerosis and Arterial Remodeling: A Pooled Analysis of 5 Intravascular Ultrasound Trials. J Am Coll Cardiol 52: 255-262 [Abstract] [Full Text]  
• White, J. R. Jr (2008). Do People With Diabetes Need Statins?. The Diabetes Educator 34: 664-673 [Abstract] [Full Text]  
• Roelker, E. (2008). Screening for Coronary Artery Disease in Patients With Diabetes. Diabetes Spectr. 21: 166-171 [Abstract] [Full Text]  
• Triplitt, C., Alvarez, C. A. (2008). Best Practices for Lowering the Risk of Cardiovascular Disease in Diabetes. Diabetes Spectr. 21: 177-189 [Abstract] [Full Text]  
• Saudek, C. D., Herman, W. H., Sacks, D. B., Bergenstal, R. M., Edelman, D., Davidson, M. B. (2008). A New Look at Screening and Diagnosing Diabetes Mellitus. J. Clin. Endocrinol. Metab. 93: 2447-2453 [Abstract] [Full Text]  
• Shishido, T., Woo, C.-H., Ding, B., McClain, C., Molina, C. A., Yan, C., Yang, J., Abe, J.-i. (2008). Effects of MEK5/ERK5 Association on Small Ubiquitin-Related Modification of ERK5: Implications for Diabetic Ventricular Dysfunction After Myocardial Infarction. Circ. Res. 102: 1416-1425 [Abstract] [Full Text]  
• van der Meer, R. W., Rijzewijk, L. J., Diamant, M., Hammer, S., Schar, M., Bax, J. J., Smit, J. W.A., Romijn, J. A., de Roos, A., Lamb, H. J. (2008). The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function. Eur Heart J 29: 1516-1522 [Abstract] [Full Text]  
• Wassink, A. M., Van Der Graaf, Y., Soedamah-Muthu, S. S, Spiering, W., Visseren, F. L. (2008). Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease. Diabetes and Vascular Disease Research 5: 114-122 [Abstract]  
• Burdon, K. P, Lehtinen, A. B, Langefeld, C. D, Carr, J. J., Rich, S. S, Freedman, B. I, Herrington, D., Bowden, D. W (2008). Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study. Diabetes and Vascular Disease Research 5: 128-134 [Abstract]  
• Natarajan, A., Zaman, A. G, Marshall, S. M (2008). Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents. Diabetes and Vascular Disease Research 5: 138-144 [Abstract]  
• Bloomgarden, Z. T. (2008). Cardiovascular Disease in Diabetes. Diabetes Care 31: 1260-1266 [Full Text]  
• Goldberg, I. J., Hu, Y., Noh, H.-L., Wei, J., Huggins, L. A., Rackmill, M. G., Hamai, H., Reid, B. N., Blaner, W. S., Huang, L.-S. (2008). Decreased Lipoprotein Clearance Is Responsible for Increased Cholesterol in LDL Receptor Knockout Mice With Streptozotocin-Induced Diabetes. Diabetes 57: 1674-1682 [Abstract] [Full Text]  
• Karalliedde, J., Smith, A., DeAngelis, L., Mirenda, V., Kandra, A., Botha, J., Ferber, P., Viberti, G. (2008). Valsartan Improves Arterial Stiffness in Type 2 Diabetes Independently of Blood Pressure Lowering. Hypertension 51: 1617-1623 [Abstract] [Full Text]  
• Mauldin, J. P., Nagelin, M. H., Wojcik, A. J., Srinivasan, S., Skaflen, M. D., Ayers, C. R., McNamara, C. A., Hedrick, C. C. (2008). Reduced Expression of ATP-Binding Cassette Transporter G1 Increases Cholesterol Accumulation in Macrophages of Patients With Type 2 Diabetes Mellitus. Circulation 117: 2785-2792 [Abstract] [Full Text]  
• Schocken, D. D., Benjamin, E. J., Fonarow, G. C., Krumholz, H. M., Levy, D., Mensah, G. A., Narula, J., Shor, E. S., Young, J. B., Hong, Y. (2008). Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 117: 2544-2565 [Abstract] [Full Text]  
• Lund, S. S, Tarnow, L., Stehouwer, C. D A, Schalkwijk, C. G, Teerlink, T., Gram, J., Winther, K., Frandsen, M., Smidt, U. M, Pedersen, O., Parving, H.-H., Vaag, A. A (2008). Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes. Eur J Endocrinol 158: 631-641 [Abstract] [Full Text]  
• Davidson, M., Meyer, P. M., Haffner, S., Feinstein, S., D'Agostino, R. Sr, Kondos, G. T., Perez, A., Chen, Z., Mazzone, T. (2008). Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus. Circulation 117: 2123-2130 [Abstract] [Full Text]  
• Goldfine, A. B., Beckman, J. A. (2008). Life and Death in Denmark: Lessons About Diabetes and Coronary Heart Disease. Circulation 117: 1914-1917 [Full Text]  
• Schramm, T. K., Gislason, G. H., Kober, L., Rasmussen, S., Rasmussen, J. N., Abildstrom, S. Z., Hansen, M. L., Folke, F., Buch, P., Madsen, M., Vaag, A., Torp-Pedersen, C. (2008). Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People. Circulation 117: 1945-1954 [Abstract] [Full Text]  
• Betteridge, D. J., DeFronzo, R. A., Chilton, R. J. (2008). PROactive: time for a critical appraisal. Eur Heart J 29: 969-983 [Abstract] [Full Text]  
• Nissen, S. E., Nicholls, S. J., Wolski, K., Nesto, R., Kupfer, S., Perez, A., Jure, H., De Larochelliere, R., Staniloae, C. S., Mavromatis, K., Saw, J., Hu, B., Lincoff, A. M., Tuzcu, E. M., for the PERISCOPE Investigators, (2008). Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes: The PERISCOPE Randomized Controlled Trial. JAMA 299: 1561-1573 [Abstract] [Full Text]  
• BAKHRU, M. R., BHATT, D. L. (2008). INTERPRETING THE CHARISMA STUDY: What is the role of dual antiplatelet therapy with clopidogrel and aspirin?. Cleveland Clinic Journal of Medicine 75: 289-295 [Abstract] [Full Text]  
• Fowler, M. J. (2008). Microvascular and Macrovascular Complications of Diabetes. Clin. Diabetes 26: 77-82 [Full Text]  
• Rossi, M. C.E., Nicolucci, A., Pellegrini, F., Comaschi, M., Ceriello, A., Cucinotta, D., Giorda, C., Valentini, U., Vespasiani, G., De Cosmo, S. (2008). Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. Nephrol Dial Transplant 23: 1278-1284 [Abstract] [Full Text]  
• Nasu, K, Tsuchikane, E, Katoh, O, Fujita, H, Surmely, J-F, Ehara, M, Kinoshita, Y, Tanaka, N, Matsubara, T, Asakura, Y, Asakura, K, Terashima, M, Suzuki, T (2008). Plaque characterisation by Virtual Histology intravascular ultrasound analysis in patients with type 2 diabetes. Heart 94: 429-433 [Abstract] [Full Text]  
• Cheurfa, N., Dubois-Laforgue, D., Ferrarezi, D. A.F., Reis, A. F., Brenner, G. M., Bouche, C., Le Feuvre, C., Fumeron, F., Timsit, J., Marre, M., Velho, G. (2008). The Common -866G>A Variant in the Promoter of UCP2 Is Associated With Decreased Risk of Coronary Artery Disease in Type 2 Diabetic Men. Diabetes 57: 1063-1068 [Abstract] [Full Text]  
• Dickinson, S., Rogers, T., Kasiske, B., Bertog, S., Tadros, G., Malik, J., Wilson, R., Panetta, C. (2008). Coronary Artery Disease in Young Women and Men With Long-Standing Insulin-dependent Diabetes. ANGIOLOGY 59: 9-15 [Abstract]  
• McGuire, D. K, Winterfield, J. R, Rytlewski, J. A, Ferrannini, E. (2008). Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus. Diabetes and Vascular Disease Research 5: 59-66 [Abstract]  
• Pearce, K. L, Noakes, M., Keogh, J., Clifton, P. M (2008). Effect of carbohydrate distribution on postprandial glucose peaks with the use of continuous glucose monitoring in type 2 diabetes. Am. J. Clin. Nutr. 87: 638-644 [Abstract] [Full Text]  
• Peter, R, Cox, A, Evans, M (2008). Management of diabetes in cardiovascular patients. Heart 94: 369-375 [Full Text]  
• Scholte, A J H A, Schuijf, J D, Kharagjitsingh, A V, Jukema, J W, Pundziute, G, van der Wall, E E, Bax, J J (2008). Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart 94: 290-295 [Abstract] [Full Text]  
• Dandona, P. (2008). Effects of Antidiabetic and Antihyperlipidemic Agents on C-Reactive Protein. Mayo Clin Proc. 83: 333-342 [Abstract] [Full Text]  
• Manrique, C., Lastra, G., Palmer, J., Gardner, M., Sowers, J. R. (2008). Review: Aspirin and Diabetes Mellitus: revisiting an old player. Ther Adv Cardiovasc Dis 2: 37-42 [Abstract]  
• HORNICK, T., ARON, D. C. (2008). Preventing and managing diabetic complications in elderly patients. Cleveland Clinic Journal of Medicine 75: 153-158 [Abstract] [Full Text]  
• Ohno, T., Takamoto, S., Motomura, N. (2008). Diabetic Retinopathy and Coronary Artery Disease From the Cardiac Surgeon's Perspective. Ann. Thorac. Surg. 85: 681-689 [Abstract] [Full Text]  
• Milicevic, Z., Raz, I., Beattie, S. D., Campaigne, B. N., Sarwat, S., Gromniak, E., Kowalska, I., Galic, E., Tan, M., Hanefeld, M. (2008). Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia. Diabetes Care 31: S155-S160 [Abstract] [Full Text]  
• Bianchi, C., Miccoli, R., Penno, G., Del Prato, S. (2008). Primary Prevention of Cardiovascular Disease in People With Dysglycemia. Diabetes Care 31: S208-S214 [Abstract] [Full Text]  
• Stirban, A. O., Tschoepe, D. (2008). Cardiovascular Complications in Diabetes: Targets and interventions. Diabetes Care 31: S215-S221 [Abstract] [Full Text]  
• Wienbergen, H., Senges, J., Gitt, A. K. (2008). Should We Prescribe Statin and Aspirin for Every Diabetic Patient?: Is it time for a polypill?. Diabetes Care 31: S222-S225 [Full Text]  
• Stirban, A. O., Tschoepe, D. (2008). Should We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?: Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?. Diabetes Care 31: S226-S228 [Abstract] [Full Text]  
• Lund, S. S, Tarnow, L., Frandsen, M., Smidt, U. M, Pedersen, O., Parving, H.-H., Vaag, A. A (2008). Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes. Eur J Endocrinol 158: 35-46 [Abstract] [Full Text]  
• Swaminathan, K., Davies, J., Struthers, A. (2008). Review: Aldosterone antagonism in type 2 diabetes mellitus -- a new therapeutic approach to diabetic macrovascular disease?. British Journal of Diabetes & Vascular Disease 8: 16-19 [Abstract]  
• Nesto, R. W. (2008). LDL Cholesterol Lowering in Type 2 Diabetes: What Is the Optimum Approach?. Clin. Diabetes 26: 8-13 [Abstract] [Full Text]  
• Amano, T., Matsubara, T., Uetani, T., Nanki, M., Marui, N., Kato, M., Yoshida, T., Arai, K., Yokoi, K., Ando, H., Kumagai, S., Ishii, H., Izawa, H., Hotta, N., Murohara, T. (2008). Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance.. J Am Coll Cardiol Img 1: 39-45 [Abstract] [Full Text]  
• Kanda, T., Wakino, S., Hayashi, K., Plutzky, J. (2008). Cardiovascular Disease, Chronic Kidney Disease, and Type 2 Diabetes Mellitus: Proceeding with Caution at a Dangerous Intersection. J. Am. Soc. Nephrol. 19: 4-7 [Full Text]  
• Kruk, M., Kadziela, J., Reynolds, H. R., Forman, S. A., Sadowski, Z., Barton, B. A., Mark, D. B., Maggioni, A. P., Leor, J., Webb, J. G., Kapeliovich, M., Marin-Neto, J. A., White, H. D., Lamas, G. A., Hochman, J. S. (2008). Predictors of Outcome and the Lack of Effect of Percutaneous Coronary Intervention Across the Risk Strata in Patients With Persistent Total Occlusion After Myocardial Infarction. Results From the Occluded Artery Trial (OAT).. J Am Coll Cardiol Intv 1: 511-520 [Abstract] [Full Text]  
• Fernandez, M., Triplitt, C., Wajcberg, E., Sriwijilkamol, A. A., Musi, N., Cusi, K., DeFronzo, R., Cersosimo, E. (2008). Addition of Pioglitazone and Ramipril to Intensive Insulin Therapy in Type 2 Diabetic Patients Improves Vascular Dysfunction by Different Mechanisms. Diabetes Care 31: 121-127 [Abstract] [Full Text]  
• Anand, D. V., Lim, E., Darko, D., Bassett, P., Hopkins, D., Lipkin, D., Corder, R., Lahiri, A. (2007). Determinants of Progression of Coronary Artery Calcification in Type 2 Diabetes: Role of Glycemic Control and Inflammatory/Vascular Calcification Markers. J Am Coll Cardiol 50: 2218-2225 [Abstract] [Full Text]  
• Hu, G., Jousilahti, P., Tuomilehto, J. (2007). Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease. Eur Heart J 28: 3059-3066 [Abstract] [Full Text]  
• Dale, A. C., Nilsen, T. I., Vatten, L., Midthjell, K., Wiseth, R. (2007). Diabetes mellitus and risk of fatal ischaemic heart disease by gender: 18 years follow-up of 74 914 individuals in the HUNT 1 Study. Eur Heart J 28: 2924-2929 [Abstract] [Full Text]  
• Kapur, A., De Palma, R. (2007). Mortality after myocardial infarction in patients with diabetes mellitus. Heart 93: 1504-1506 [Abstract] [Full Text]